Skip to main content
All lobbying filings

TODD STRATEGY GROUP

Lobbying for KALEO · Pharmaceutical company.

 Filing Q2 termination
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 12, 2026
Income
$40,000.00
What the client paid this registrant for the period.
Client based in
Virginia
Representation ended
Jun 30, 2026
The registrant reported terminating its work for this client.

Official filing document

 Lobbyists on this filing 2
  • PAUL EDATTEL
    Previously held: Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
  • NICHOLAS UEHLECKE
    Previously held: Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Prescription drug pricing. Medical countermeasure development and procurement.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem